Effects of Chemotherapy on Hematological Parameters and CD4+/CD8+ Ratio in Cats with Mediastinal Lymphoma and Seropositive to Feline Leukemia Virus
Open Access
Abstract
The objective of this study was to evaluate the effect of the COP chemotherapeutic protocol on hematological parameters, CD4+/CD8+ ratio, and the mortality of 18 client-owned FeLV-infected cats with mediastinal lymphoma. The complete blood count, creatinine, alanine aminotransferase, and CD4+/CD8+ ratio were measured four times before treating with chemotherapy in the 1st, 2nd, 3rd, and 4th weeks. The white blood cell (WBC) counts at the 1st week were significantly different from the 2nd, 3rd, and 4th inductions (p = 0.0075, p = p = 0.0271, respectively). The neutrophils at the 1st week were significantly different from the 2nd and 3rd inductions (p = 0.0179, and p < 0.0001, respectively). The packed cell volume (PCV) at the 1st week was significantly differed from the 2nd, 3rd, and 4th induction times (p = 0.0029, p = 0.0006, and p = 0.0029, respectively. The mean corpuscular volume (MCV) at the 1st week was significantly different from the 4th week (p = 0.0145). We found that chemotherapy did not cause any significant change in the CD4+/CD8+ ratio (p-value 0.7407). The Kaplan–Meier curves showed the median survival time (MST) for the cats with a CD4+/CD8 ratio of less than 1 after the 1st week of chemotherapy was 134 days. This suggested that COP chemotherapy was a safe treatment for FeLV-infected cats with mediastinal lymphoma.Keywords
Funding Information
- Faculty of Veterinary Medicine, Kasetsart University (-)
This publication has 38 references indexed in Scilit:
- Clinical Aspects of Feline Retroviruses: A ReviewViruses, 2012
- Entourage: the immune microenvironment following follicular lymphomaBlood Cancer Journal, 2012
- Prognostic Significance of Weight Changes during Treatment of Feline LymphomaJournal of Feline Medicine and Surgery, 2011
- Feline extranodal lymphoma: response to chemotherapy and survival in 110 catsJournal of Small Animal Practice, 2009
- The immune risk phenotype is associated with IL-6 in the terminal decline stage: Findings from the Swedish NONA immune longitudinal study of very late life functioningMechanisms of Ageing and Development, 2006
- Chemotherapy with Cyclophosphamide, Vincristine, and Prednisolone (COP) in Cats with Malignant Lymphoma: New Results with an Old ProtocolJournal of Veterinary Internal Medicine, 2002
- What is New on Feline Lymphoma?Journal of Feline Medicine and Surgery, 2001
- Advances in the Treatment of the Cat with Lymphoma in PracticeJournal of Feline Medicine and Surgery, 2000
- Molecular analysis of tumours from feline immunodeficiency virus (FIV)‐infected cats: An indirect role for FIV?International Journal of Cancer, 1995
- Laboratory control values for CD4 and CD8 T lymphocytes. Implications for HIV-1 diagnosisClinical and Experimental Immunology, 1992